Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-028453

Chief Financial Officer sold 87,339 shares at an average $26.45 ($2,310,106)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2021-04-22 Sale −30,000 $26.84 $805,218 209,059 D
Ruffo Frank Chief Financial Officer 2021-04-23 Sale −29,200 $26.64 $777,797 179,859 D
Ruffo Frank Chief Financial Officer 2021-04-23 Sale −800 $27.33 $21,863 179,059 D
Ruffo Frank Chief Financial Officer 2021-04-26 Sale −27,239 $25.79 $702,584 151,820 D
Ruffo Frank Chief Financial Officer 2021-04-26 Sale −100 $26.44 $2,644 151,720 D
Open-market sales · 87,339 sh · avg $26.45 · $2,310,106
Loading xslF345X03/doc4.xml…